Metabolic response to endotoxin in vivo in the conscious mouse: Role of interleukin-6

Metabolism: Clinical and Experimental

Volumn 60, Issue 1, 2011, Pages 92-98

  Tweedell, Andrea ^a   Mulligan, Kimberly X ^a   Martel, Josie E ^a   Chueh, Fu Yu ^a   Santomango, Tammy ^a   McGuinness, Owen P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI ENDOTOXIN; GLUCAGON; GLUCOSE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG DOSE INCREASE; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEMATOCRIT; HORMONE RESPONSE; HYPOGLYCEMIA; IN VIVO STUDY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TISSUE LEVEL; VEIN CATHETERIZATION;

ANIMALS; CATECHOLAMINES; GLUCAGON; GLUCOSE; INSULIN; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649905984     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.12.022     Document Type: Article

References (31)

1. Wheeler A.P., and Bernard G.R. Treating patients with severe sepsis N Engl J Med 340 1999 207 214
2. Lang C.H., Bagby G.J., and Spitzer J.J. Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin Am J Physiol 248 1985 R471 R478
3. Meinz H.M., Lacy D.B., Ejiofor J., and McGuinness O.P. Alterations in hepatic gluconeogenic amino acid uptake and gluconeogenesis in the endotoxin treated conscious dog Shock 9 1998 296 303
4. Harizi H., Homo-Delarche F., Amrani A., Coulaud J., and Mormède P. Marked genetic differences in the regulation of blood glucose under immune and restraint stress in mice reveals a wide range of corticosensitivity J Neuroimmunol 189 2007 59 68
5. Hesse D.G., Tracey K.J., Fong Y., Manogue K.R., Palladino M.A. Jr., and Cerami A. Cytokine appearance in human endotoxemia and primate bacteremia Surg Gynecol Obstet 166 1988 147 153
6. Copeland S., Warren H.S., Lowry S.F., Calvano S.E., and Remick D. Acute inflammatory response to endotoxin in mice and humans Clin Diagn Lab Immunol 12 2005 60 67
7. Meszaros K., Bagby G.J., Lang C.H., and Spitzer J.J. Increased uptake and phosphorylation of 2-deoxyglucose by skeletal muscles in endotoxin-treated rats Am J Physiol 253 1987 E33 E39
8. Meszaros K., Bojta J., Bautista A.P., Lang C.H., and Spitzer J.J. Glucose utilization by Kupffer cells, endothelial cells, and granulocytes in endotoxemic rat liver Am J Physiol 260 Pt 1 1991 G7 G12
9. Meszaros K., Lang C.H., Bagby G.J., and Spitzer J.J. Contribution of different organs to increased glucose consumption after endotoxin administration J Biol Chem 262 1987 10965 10970
10. Meszaros K., Lang C.H., Bagby G.J., and Spitzer J.J. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues Biochem Biophys Res Commun 149 1987 1 6
11. Bagby G.J., Lang C.H., Skrepnik N., Golightly G., and Spitzer J.J. Regulation of glucose metabolism after endotoxin and during infection is largely independent of endogenous tumor necrosis factor Circ Shock 39 1993 211 219
12. Del Rey A., and Besedovsky H.O. Metabolic and neuroendocrine effects of pro- inflammatory cytokines Eur J Clin Invest 22 Suppl 1 1992 10 15
13. Carey A.L., Steinberg G.R., Macaulay S.L., Thomas W.G., Holmes A.G., and Ramm G. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 55 2006 2688 2697
14. Kim H.J., Higashimori T., Park S.Y., Choi H., Dong J., and Kim Y.J. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo Diabetes 53 2004 1060 1067
15. Klover P.J., Zimmers T.A., Koniaris L.G., and Mooney R.A. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice Diabetes 52 2003 2784 2789
16. Krogh-Madsen R., Plomgaard P., Moller K., Mittendorfer B., and Pedersen B.K. Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans Am J Physiol Endocrinol Metab 291 2006 E108 E114
17. Pedersen B.K., Febbraio M.A., and Mooney R.A. Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis J Appl Physiol 2006
18. Weigert C., Hennige A.M., Lehmann R., Brodbeck K., Baumgartner F., and Schauble M. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells J Biol Chem 281 2006 7060 7067
19. Ayala J.E., Bracy D., McGuinness O.P., and Wasserman D.H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse Diabetes 55 2006 390 397
20. Niswender K.D., Shiota M., Postic C., Cherrington A.D., and Magnuson M.A. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism J Biol Chem 272 1997 22570 22575
21. Wall J.S., Steele R., De Bodo R.C., and Altszuler N. Effect of insulin on utilization and production of circulating glucose Am J Physiol 189 1957 43 50
22. Kraegen E.W., James D.E., Jenkins A.B., and Chisholm D.J. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats Am J Physiol 248 1985 E353 E362
23. Agwunobi A.O., Reid C., Maycock P., Little R.A., and Carlson G.L. Insulin resistance and substrate utilization in human endotoxemia J Clin Endocrinol Metab 85 2000 3770 3778
24. Krogh-Madsen R., Moller K., Dela F., Kronborg G., Jauffred S., and Pedersen B.K. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans Am J Physiol 286 2004 E766 E772
25. Hargrove D.M., Bagby G.J., Lang C.H., and Spitzer J.J. Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism Am J Physiol 255 1988 E629 E635
26. Di Gregorio G.B., Hensley L., Lu T., Ranganathan G., and Kern P.A. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity Am J Physiol Endocrinol Metab 287 2004 E182 E187
27. Nieto-Vazquez I., Fernãíndez-Veledo S., de Alvaro C., and Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle Diabetes 57 2008 3211 3221
28. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., and Carelli M. Defective inflammatory response in interleukin 6-deficient mice J Exp Med 180 1994 1243 1250
29. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., and Delvaux A. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia J Exp Med 177 1993 547 550
30. Beutler B., Milsark I.W., and Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869 871
31. Ellingsgaard H., Ehses J.A., Hammar E.B., Van Lommel L., Quintens R., and Martens G. Interleukin-6 regulates pancreatic alpha-cell mass expansion Proc Natl Acad Sci U S A 105 2008 13163 13168